Skip to content

Hemodynamic Monitoring of Newborn Infants With Impedance Cardiography Versus Echocardiography; a Validation Study

Hemodynamic Monitoring of Newborn Infants With Impedance Cardiography Versus Echocardiography; a Validation Study

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03867825
Enrollment
0
Registered
2019-03-08
Start date
2020-01-31
Completion date
2020-12-31
Last updated
2019-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamics

Brief summary

Background: Impedance cardiography (ICG) is a noninvasive method for continuous left cardiac output monitoring based on measurement of thoracic electrical bioimpedance. The objective of this study is to validate an ICG device by investigating the agreement in cardiac output (CO; left ventricular output x heart rate) measurements performed by ICG and echocardiography. The ICG device (PhysioFlow) has a new filter technology reducing signal noise and enabling measurements in patients who are moving freely. Material and Methods * Design: Prospective observational study. * Inclusion: 30 healthy term infants between 24 and 48 hours of age, after parental consent * Methods: Continuous measurement with ICG over a 30 min period and point of care echocardiography * Primary outcome: Agreement (bis and precision) between measurement of CO with ICG and echocardiography. * Secondary outcomes: Agreement between other echocardiographic indices of myocardial function and ICG parameters (early diastolic filling ratio, cardiac index, ventricular ejection time and left cardiac work index). * Statistics: Agreement between ICG and echocardiography data will be evaluated using Bland-Altman statistics, including the calculation of mean bias (average difference between measurements) with corresponding standard deviation and lower and upper limits of agreements (95% confidence interval).

Interventions

DEVICENon-invasive hemodynamic monitoring

Impedance cardiography

Sponsors

Knut Helge Kaspersen, MD
CollaboratorUNKNOWN
Per Ivar Kaaresen, MD, PhD
CollaboratorUNKNOWN
Nils Thomas Songstad, MD, PhD
CollaboratorUNKNOWN
Ganesh Acharya, Professor
CollaboratorUNKNOWN
University Hospital of North Norway
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Months

Inclusion criteria

* Newborn infants

Exclusion criteria

* Infants \> 1 month of age

Design outcomes

Primary

MeasureTime frameDescription
Cardiac outputone hourStroke volume x heart rate

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026